AGIO financials
Agios Pharmaceuticals (AGIO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
AGIO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $54.03M | $42.51M | -$472.13M | -$412.78M | -7.12 |
| 2024 | $36.50M | $32.33M | -$425.74M | $673.73M | 11.64 |
| 2023 | $26.82M | $17.32M | -$391.49M | -$352.09M | -6.33 |
| 2022 | $14.24M | $12.54M | -$389.05M | -$231.80M | -4.23 |
| 2021 | $0.00 | -$18.78M | -$378.42M | $1.60B | -6.36 |
| 2020 | $0.00 | -$18.77M | -$335.92M | -$327.37M | -4.74 |
- AGIO revenue was $54.03M in fiscal 2025, net income -$412.78M.
Updated 2026-11-04 02:06 UTC